Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the provision of development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
268
Frequently Asked Questions
What is Market Cap of Harmony Biosciences Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Harmony Biosciences Holdings Inc market cap is $1.86B.
What is the 52-week high for Harmony Biosciences Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Harmony Biosciences Holdings Inc 52 week high is $41.61 as of September 13, 2025.
What is the 52-week low for Harmony Biosciences Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Harmony Biosciences Holdings Inc 52 week low is $26.47 as of September 13, 2025.
What is Harmony Biosciences Holdings Inc stock price today?
Harmony Biosciences Holdings Inc stock price today is $32.39.
What was Harmony Biosciences Holdings Inc stock price yesterday?
Harmony Biosciences Holdings Inc stock price yesterday was $33.42.
What is the PE ratio of Harmony Biosciences Holdings Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Harmony Biosciences Holdings Inc’s P/E ratio is 10.44.
What is the Price-to-Book ratio of Harmony Biosciences Holdings Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Harmony Biosciences Holdings Inc P/B ratio is 2.4107.
What is the 50-day moving average of Harmony Biosciences Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Harmony Biosciences Holdings Inc 50-day moving average is $35.55.
How many employess does Harmony Biosciences Holdings Inc has?
Harmony Biosciences Holdings Inc has 268 employees.